The nuclear imaging devices and equipment market size has grown steadily in recent years. It will grow from $4 billion in 2025 to $4.13 billion in 2026 at a compound annual growth rate (CAGR) of 3.3%. The growth in the historic period can be attributed to growing incidence of chronic diseases, expansion of nuclear medicine departments in hospitals, increasing availability of radiotracers, adoption of advanced diagnostic imaging protocols, rising demand for early disease detection.
The nuclear imaging devices and equipment market size is expected to see steady growth in the next few years. It will grow to $4.71 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to increasing investments in precision diagnostics, rising adoption of hybrid imaging technologies, expansion of nuclear cardiology and oncology imaging, growing focus on low-dose imaging solutions, increasing integration of ai-driven diagnostics. Major trends in the forecast period include increasing adoption of hybrid pet/ct and spect/ct systems, rising demand for advanced oncology imaging, growing integration of ai in image reconstruction, expansion of molecular imaging applications, enhanced focus on diagnostic accuracy and workflow efficiency.
The rising prevalence of chronic conditions is anticipated to drive the expansion of the nuclear imaging devices and equipment market in the coming years. Chronic conditions, also referred to as chronic diseases, are long-term medical issues that endure over an extended period, typically lasting three months or longer. Nuclear imaging devices and equipment facilitate the diagnosis and monitoring of chronic diseases by offering critical insights into disease progression, treatment effectiveness, and patient care. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that by 2050, over 35 million new cancer cases were expected, marking a 77% increase compared to the estimated 20 million cases in 2022. Consequently, the growing prevalence of chronic conditions is fueling the demand for nuclear imaging devices and equipment.
Major companies in the nuclear imaging devices and equipment market are increasingly investing in deep learning-based image processing solutions to improve diagnostic precision, lesion detectability, and operational efficiency. Deep learning, a branch of artificial intelligence, employs neural networks trained on extensive datasets to enhance image reconstruction, minimize noise, and enable accurate quantitative assessments. For example, in May 2023, GE HealthCare, a U.S.-based medical technology firm, obtained U.S. FDA 510(k) clearance for its Precision DL software, designed for its Omni Legend PET/CT system. This AI-driven solution provides, on average, an 11 % enhancement in contrast recovery, a 23 % increase in contrast-to-noise ratio, a 42 % improvement in detectability of small low-contrast lesions, and a 14 % gain in quantitative accuracy, thereby facilitating earlier detection and more confident clinical decision-making.
In April 2024, Spectrum Dynamics Medical, a US-based producer of nuclear imaging devices, formed a partnership with Hermes Medical Solutions to enhance nuclear medicine through integrated, vendor-neutral imaging solutions. The collaboration seeks to merge Hermes’ Hermia software with Spectrum’s VERITON-CT scanner, allowing advanced image processing, quantitative analysis, and theranostic dosimetry to optimize nuclear medicine workflows and elevate patient care. Hermes Medical Solutions is a Sweden-based medical software firm.
Major companies operating in the nuclear imaging devices and equipment market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Neusoft Medical Systems Co Ltd, Mediso Medical Imaging Systems Ltd, Digirad Corporation, CMR Naviscan Corporation, Shimadzu Corporation, Toshiba Medical Systems Corporation, DDD Diagnostics A/S, MILabs B.V., MR Solutions Ltd, SurgicEye GmbH, United Imaging Healthcare, Positron Corporation, Spectrum Dynamics Medical, Berthold Technologies GmbH & Co KG, Gamma Medica Inc, Cubresa Inc, PerkinElmer Inc.
Western Europe was the largest region in nuclear imaging devices and equipment market in 2025. North America was the second-largest region in nuclear imaging devices and equipment market. The regions covered in the nuclear imaging devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nuclear imaging devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the nuclear imaging devices and equipment market by increasing costs of imported detectors, imaging electronics, gantry systems, and precision components. Hospitals and imaging centers in North America and Europe are most affected due to reliance on imported high-value imaging equipment, while Asia-Pacific faces cost pressure on system manufacturing and exports. These tariffs are increasing capital investment requirements and delaying system upgrades. However, they are also supporting local assembly, regional component sourcing, and domestic innovation in nuclear imaging technologies.
The nuclear imaging devices and equipment market research report is one of a series of new reports that provides nuclear imaging devices and equipment market statistics, including nuclear imaging devices and equipment industry global market size, regional shares, competitors with a nuclear imaging devices and equipment market share, detailed nuclear imaging devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear imaging devices and equipment industry. This nuclear imaging devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nuclear imaging devices and equipment play a crucial role in disease diagnosis, utilizing small amounts of radioactive substances administered to patients. They find extensive applications in various medical fields, including cardiology, obstetrics/gynecology, vascular studies, urology, and other medical applications.
The primary product categories within nuclear imaging devices and equipment include SPECT systems, PET systems, and planar scintigraphy. SPECT systems are employed to capture images and generate 3D scans, serving a range of applications such as oncology, cardiology, neurology, as well as other medical domains such as orthopedics, urology, thyroid-related disorders, and gastroenterology. These devices are utilized in diverse healthcare settings, including hospitals, imaging centers, academic and research institutes, as well as other end-users such as pharmaceutical/biotechnology companies and Contract Research Organizations (CROs).
The nuclear imaging devices and equipment market consist of sales of SPECT (single-photon emission computed tomography) systems, hybrid PET systems, and planar scintigraphy imaging systems. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The nuclear imaging devices and equipment market size is expected to see steady growth in the next few years. It will grow to $4.71 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to increasing investments in precision diagnostics, rising adoption of hybrid imaging technologies, expansion of nuclear cardiology and oncology imaging, growing focus on low-dose imaging solutions, increasing integration of ai-driven diagnostics. Major trends in the forecast period include increasing adoption of hybrid pet/ct and spect/ct systems, rising demand for advanced oncology imaging, growing integration of ai in image reconstruction, expansion of molecular imaging applications, enhanced focus on diagnostic accuracy and workflow efficiency.
The rising prevalence of chronic conditions is anticipated to drive the expansion of the nuclear imaging devices and equipment market in the coming years. Chronic conditions, also referred to as chronic diseases, are long-term medical issues that endure over an extended period, typically lasting three months or longer. Nuclear imaging devices and equipment facilitate the diagnosis and monitoring of chronic diseases by offering critical insights into disease progression, treatment effectiveness, and patient care. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that by 2050, over 35 million new cancer cases were expected, marking a 77% increase compared to the estimated 20 million cases in 2022. Consequently, the growing prevalence of chronic conditions is fueling the demand for nuclear imaging devices and equipment.
Major companies in the nuclear imaging devices and equipment market are increasingly investing in deep learning-based image processing solutions to improve diagnostic precision, lesion detectability, and operational efficiency. Deep learning, a branch of artificial intelligence, employs neural networks trained on extensive datasets to enhance image reconstruction, minimize noise, and enable accurate quantitative assessments. For example, in May 2023, GE HealthCare, a U.S.-based medical technology firm, obtained U.S. FDA 510(k) clearance for its Precision DL software, designed for its Omni Legend PET/CT system. This AI-driven solution provides, on average, an 11 % enhancement in contrast recovery, a 23 % increase in contrast-to-noise ratio, a 42 % improvement in detectability of small low-contrast lesions, and a 14 % gain in quantitative accuracy, thereby facilitating earlier detection and more confident clinical decision-making.
In April 2024, Spectrum Dynamics Medical, a US-based producer of nuclear imaging devices, formed a partnership with Hermes Medical Solutions to enhance nuclear medicine through integrated, vendor-neutral imaging solutions. The collaboration seeks to merge Hermes’ Hermia software with Spectrum’s VERITON-CT scanner, allowing advanced image processing, quantitative analysis, and theranostic dosimetry to optimize nuclear medicine workflows and elevate patient care. Hermes Medical Solutions is a Sweden-based medical software firm.
Major companies operating in the nuclear imaging devices and equipment market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Neusoft Medical Systems Co Ltd, Mediso Medical Imaging Systems Ltd, Digirad Corporation, CMR Naviscan Corporation, Shimadzu Corporation, Toshiba Medical Systems Corporation, DDD Diagnostics A/S, MILabs B.V., MR Solutions Ltd, SurgicEye GmbH, United Imaging Healthcare, Positron Corporation, Spectrum Dynamics Medical, Berthold Technologies GmbH & Co KG, Gamma Medica Inc, Cubresa Inc, PerkinElmer Inc.
Western Europe was the largest region in nuclear imaging devices and equipment market in 2025. North America was the second-largest region in nuclear imaging devices and equipment market. The regions covered in the nuclear imaging devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nuclear imaging devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the nuclear imaging devices and equipment market by increasing costs of imported detectors, imaging electronics, gantry systems, and precision components. Hospitals and imaging centers in North America and Europe are most affected due to reliance on imported high-value imaging equipment, while Asia-Pacific faces cost pressure on system manufacturing and exports. These tariffs are increasing capital investment requirements and delaying system upgrades. However, they are also supporting local assembly, regional component sourcing, and domestic innovation in nuclear imaging technologies.
The nuclear imaging devices and equipment market research report is one of a series of new reports that provides nuclear imaging devices and equipment market statistics, including nuclear imaging devices and equipment industry global market size, regional shares, competitors with a nuclear imaging devices and equipment market share, detailed nuclear imaging devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear imaging devices and equipment industry. This nuclear imaging devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nuclear imaging devices and equipment play a crucial role in disease diagnosis, utilizing small amounts of radioactive substances administered to patients. They find extensive applications in various medical fields, including cardiology, obstetrics/gynecology, vascular studies, urology, and other medical applications.
The primary product categories within nuclear imaging devices and equipment include SPECT systems, PET systems, and planar scintigraphy. SPECT systems are employed to capture images and generate 3D scans, serving a range of applications such as oncology, cardiology, neurology, as well as other medical domains such as orthopedics, urology, thyroid-related disorders, and gastroenterology. These devices are utilized in diverse healthcare settings, including hospitals, imaging centers, academic and research institutes, as well as other end-users such as pharmaceutical/biotechnology companies and Contract Research Organizations (CROs).
The nuclear imaging devices and equipment market consist of sales of SPECT (single-photon emission computed tomography) systems, hybrid PET systems, and planar scintigraphy imaging systems. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Nuclear Imaging Devices and Equipment Market Characteristics
3. Nuclear Imaging Devices and Equipment Market Supply Chain Analysis
4. Global Nuclear Imaging Devices and Equipment Market Trends and Strategies
5. Nuclear Imaging Devices and Equipment Market Analysis of End Use Industries
7. Global Nuclear Imaging Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Nuclear Imaging Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Nuclear Imaging Devices and Equipment Market Segmentation
10. Nuclear Imaging Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Nuclear Imaging Devices and Equipment Market
12. China Nuclear Imaging Devices and Equipment Market
13. India Nuclear Imaging Devices and Equipment Market
14. Japan Nuclear Imaging Devices and Equipment Market
15. Australia Nuclear Imaging Devices and Equipment Market
16. Indonesia Nuclear Imaging Devices and Equipment Market
17. South Korea Nuclear Imaging Devices and Equipment Market
18. Taiwan Nuclear Imaging Devices and Equipment Market
19. South East Asia Nuclear Imaging Devices and Equipment Market
20. Western Europe Nuclear Imaging Devices and Equipment Market
21. UK Nuclear Imaging Devices and Equipment Market
22. Germany Nuclear Imaging Devices and Equipment Market
23. France Nuclear Imaging Devices and Equipment Market
24. Italy Nuclear Imaging Devices and Equipment Market
25. Spain Nuclear Imaging Devices and Equipment Market
26. Eastern Europe Nuclear Imaging Devices and Equipment Market
27. Russia Nuclear Imaging Devices and Equipment Market
28. North America Nuclear Imaging Devices and Equipment Market
29. USA Nuclear Imaging Devices and Equipment Market
30. Canada Nuclear Imaging Devices and Equipment Market
31. South America Nuclear Imaging Devices and Equipment Market
32. Brazil Nuclear Imaging Devices and Equipment Market
33. Middle East Nuclear Imaging Devices and Equipment Market
34. Africa Nuclear Imaging Devices and Equipment Market
36. Nuclear Imaging Devices and Equipment Market Competitive Landscape and Company Profiles
37. Nuclear Imaging Devices and Equipment Market Other Major and Innovative Companies
40. Nuclear Imaging Devices and Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Nuclear Imaging Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses nuclear imaging devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for nuclear imaging devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nuclear imaging devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: SPECT Systems; PET Systems; Planar Scintigraphy Systems2) By Application: Oncology; Cardiology; Neurology; Other Applications
3) By End-User: Hospitals; Imaging Centers; Academic & Research Institutes; Other End-Users
Subsegments:
1) By SPECT Systems: Single-Photon Emission Computed Tomography (SPECT) Cameras; Hybrid SPECT/CT Systems; SPECT Probes2) By PET Systems: Positron Emission Tomography (PET) Scanners; Hybrid PET/CT Systems; PET Probes
3) By Planar Scintigraphy Systems: Gamma Cameras; Dual-Head Gamma Cameras; Single-Head Gamma Cameras
Companies Mentioned: Siemens Healthineers AG; GE Healthcare; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Neusoft Medical Systems Co Ltd; Mediso Medical Imaging Systems Ltd; Digirad Corporation; CMR Naviscan Corporation; Shimadzu Corporation; Toshiba Medical Systems Corporation; DDD Diagnostics A/S; MILabs B.V.; MR Solutions Ltd; SurgicEye GmbH; United Imaging Healthcare; Positron Corporation; Spectrum Dynamics Medical; Berthold Technologies GmbH & Co KG; Gamma Medica Inc; Cubresa Inc; PerkinElmer Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Nuclear Imaging Devices and Equipment market report include:- Siemens Healthineers AG
- GE Healthcare
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Neusoft Medical Systems Co Ltd
- Mediso Medical Imaging Systems Ltd
- Digirad Corporation
- CMR Naviscan Corporation
- Shimadzu Corporation
- Toshiba Medical Systems Corporation
- DDD Diagnostics A/S
- MILabs B.V.
- MR Solutions Ltd
- SurgicEye GmbH
- United Imaging Healthcare
- Positron Corporation
- Spectrum Dynamics Medical
- Berthold Technologies GmbH & Co KG
- Gamma Medica Inc
- Cubresa Inc
- PerkinElmer Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.13 Billion |
| Forecasted Market Value ( USD | $ 4.71 Billion |
| Compound Annual Growth Rate | 3.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
